Sacha , Tomasz. “Deep Molecular Response (MR4.5) As a Target of Therapy With Tyrosine Kinase Inhibitors. MR4.5 – Goal of CML Treatment”. OncoReview 4, no. 1(13) (March 31, 2014): 26-32. Accessed November 23, 2024. https://journalsmededu.pl/index.php/OncoReview/article/view/356.